Publication:
Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

Placeholder

Organizational Units

Program

Authors

Authors

Deniz, Semanur
SANCAR, MESUT
OKUYAN, BETÜL
ATA, PINAR
Ozakpinar, Ozlem Bingol
TALAS, Anil
GUNES, Tufan
CALISKAN, Mecit
Izzettin, Fikret Vehbi

Advisor

Date

2016-06-01T00:00:00Z

Language

Type

Article

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: The aim of this study is to determine relationship of cytochrome P-450 2C19 (CYP2C19) enzymes polymorphism, side effects, and medication adherence in patients who have been diagnosed with major depression and have utilized selective serotonin reuptake inhibitors.

Description

Source:

Keywords:

Keywords

Citation

Deniz S., SANCAR M., OKUYAN B., ATA P., Ozakpinar O. B. , TALAS A., GUNES T., CALISKAN M., Izzettin F. V. , -Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors-, KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, ss.152-160, 2016

URI

http://hdl.handle.net/20.500.12645/25695

Collections

Yayınlar - Eserler

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals